Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DENTSPLY SIRONA Inc. - Common Stock (NQ:XRAY)

16.57 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DENTSPLY SIRONA Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Dental Equipment & Technology Q1 Earnings: Dentsply Sirona (NASDAQ:XRAY) Simply the Best
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the dental equipment & technology industry, including Dentsply Sirona (NASDAQ:XRAY) and its peers. 
Via StockStory
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
3 Cash-Producing Stocks with Bad Fundamentals
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
3 Low-Volatility Stocks in Dangerous Territory
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
Earnings Scheduled For May 8, 2025
Via Benzinga
XRAY Q1 Earnings Call: Margin Gains Amid Tariff and Market Pressures
Dental products company Dentsply Sirona (NASDAQ:XRAY) beat Wall Street’s revenue expectations in Q1 CY2025. Its non-GAAP EPS of $0.43 per share was 43% above analysts’ consensus estimates. 
Via StockStory
Topics World Trade
Luxfer, LGI Homes, QuidelOrtho, Dentsply Sirona, and AdaptHealth Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +2.0%) as President Trump postponed the planned 50% tariff on European Union imports,... 
Via StockStory
Topics Government Stocks World Trade
3 Stocks Under $50 Walking a Fine Line
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Winners And Losers Of Q1: Align Technology (NASDAQ:ALGN) Vs The Rest Of The Dental Equipment & Technology Stocks
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Align Technology (NASDAQ:ALGN) and its peers. 
Via StockStory
3 Healthcare Stocks Walking a Fine Line
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
3 of Wall Street’s Favorite Stocks Walking a Fine Line
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Neogen, Dentsply Sirona, Acadia Healthcare, Universal Health Services, and Mettler-Toledo Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
Breaking Down Dentsply Sirona: 9 Analysts Share Their Views
Via Benzinga
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Dentsply Sirona Stock Is Rallying The Most Since 2019 on Thursday – What's Driving It?
Dentsply Sirona topped Q1 estimates, raised 2025 sales outlook, and reaffirmed EPS guidance, pushing shares higher despite macroeconomic pressures. 
Via Benzinga
Dentsply Sirona (NASDAQ:XRAY) Beats Expectations in Strong Q1, Stock Soars
Dental products company Dentsply Sirona (NASDAQ:XRAY) announced better-than-expected revenue in Q1 CY2025, but sales fell by 7.8% year on year to $879 million. The company’s full-year revenue guidance... 
Via StockStory
What To Expect From Dentsply Sirona’s (XRAY) Q1 Earnings
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting earnings tomorrow morning. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
1 Unprofitable Stock Worth Investigating and 2 to Approach with Caution
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
Topics Energy
1 Value Stock on Our Buy List and 2 to Ignore
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
Q4 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks
Let’s dig into the relative performance of Dentsply Sirona (NASDAQ:XRAY) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season. 
Via StockStory
3 Cash-Producing Stocks Facing Headwinds
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Q4 Earnings Highs And Lows: Envista (NYSE:NVST) Vs The Rest Of The Dental Equipment & Technology Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Envista (NYSE:NVST) and the best and worst... 
Via StockStory
3 Reasons to Avoid XRAY and 1 Stock to Buy Instead
Dentsply Sirona’s stock price has taken a beating over the past six months, shedding 46.9% of its value and falling to $12.92 per share. This was partly due to its softer quarterly results and may have... 
Via StockStory
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields
Via Benzinga
3 Stocks Under $50 Skating on Thin Ice
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Dental Players Dentsply Sirona, ZimVie Show Weak Growth Outlook: Analyst
Needham downgraded Dentsply Sirona and ZimVie, citing weak growth, market share losses, and demand challenges amid high interest rates and soft consumer sentiment. 
Via Benzinga
This UiPath Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday
Via Benzinga
3 Value Stocks Skating on Thin Ice
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.